Page last updated: 2024-09-05

lenalidomide and Stevens-Johnson Syndrome

lenalidomide has been researched along with Stevens-Johnson Syndrome in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	10 (83.33)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Chen, G; Chen, Z; Du, K; Li, Y; Zhang, J	1
Chaudhry, QUN; Iftikhar, R; Khan, MA; Mahmood, SK; Satti, TM; Shahbaz, N	1
Aoyama, K; Arakawa, F; Morishige, S; Mouri, F; Nagafuji, K; Nakamura, T; Nishi, M; Ohshima, K; Osaki, K; Oya, S; Saruta, H; Seki, R; Yamaguchi, M; Yamasaki, Y	1
Inoue, Y; Isobe, Y; Kato, M; Miura, I; Nishio, Y; Saito, T; Sakai, H; Sato, K; Suzuki, Y; Takahashi, M; Tsuruoka, Y	1
Abe, T; Arihara, Y; Fujii, S; Fujita, M; Hirako, T; Jomen, W; Kato, J; Kuroda, H; Maeda, M; Miura, S; Nagashima, K; Sakurai, T; Yamada, M; Yoshida, M	1
Brandenburg, NA; Burton, GH; Bwire, R; Castaneda, CP; Zeldis, JB	1
Engelhardt, M; Finke, J; Jakob, T; Technau, K; Wäsch, R	1
Allegra, A; Alonci, A; Catena, S; D'Angelo, A; Gerace, D; Greve, B; Musolino, C; Penna, G; Russo, S	1
Bolesta, S; Boruah, PK; Shetty, SM	1
Caravita, T; De Bellis, A; de Fabritiis, P; Dentamaro, T; Morino, L; Musto, P; Perrotti, A; Siniscalchi, A; Tendas, A	1
Allegra, A; Alonci, A; Catena, S; Musolino, C; Rizzotti, P; Rotondo, F; Russo, S	1

Reviews

1 review(s) available for lenalidomide and Stevens-Johnson Syndrome

Article	Year
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. Hematological oncology, 2012, Volume: 30, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lenalidomide; Multiple Myeloma; Prednisolone; Stevens-Johnson Syndrome; Thalidomide	2012

Other Studies

11 other study(ies) available for lenalidomide and Stevens-Johnson Syndrome

Article	Year
Different human leukocyte antigen allele related to toxic epidermal necrolysis following lenalidomide treatment for multiple myeloma in a severely allergic family. International journal of dermatology, 2023, Volume: 62, Issue:8 Topics: Alleles; HLA Antigens; Humans; Hypersensitivity; Lenalidomide; Multiple Myeloma; Stevens-Johnson Syndrome	2023
Lenalidomide Induced Toxic Epidermal Necrolysis and Del (5q): Co-occurrence of Rarities. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:6 Topics: Anemia, Macrocytic; Calreticulin; Chromosome Deletion; Chromosomes, Human, Pair 5; Cytogenetics; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Primary Myelofibrosis; Stevens-Johnson Syndrome	2018
Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation. International journal of hematology, 2019, Volume: 110, Issue:4 Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Methylprednisolone; Pulse Therapy, Drug; Recurrence; Stevens-Johnson Syndrome; Transplantation, Haploidentical; Treatment Outcome	2019
Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myeloma. Thrombosis research, 2013, Volume: 132, Issue:4 Topics: HMGB1 Protein; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Recombinant Proteins; Stevens-Johnson Syndrome; Thalidomide; Thrombomodulin	2013
[A case in which chromosome 5q deletion syndrome resistant to lenalidomide therapy transformed to refractory anemia with excess blasts]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:13 Topics: Aged, 80 and over; Anemia, Macrocytic; Chromosome Deletion; Chromosomes, Human, Pair 5; Fatal Outcome; Humans; Lenalidomide; Male; Stevens-Johnson Syndrome; Thalidomide	2013
Erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jan-01, Volume: 27, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Erythema Multiforme; Female; Humans; Lenalidomide; Male; Middle Aged; Stevens-Johnson Syndrome; Thalidomide	2009
Lenalidomide: Stevens-Johnson syndrome. Prescrire international, 2010, Volume: 19, Issue:107 Topics: Antineoplastic Agents; Humans; Lenalidomide; Stevens-Johnson Syndrome; Thalidomide	2010
Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation. Annals of hematology, 2012, Volume: 91, Issue:2 Topics: Antineoplastic Agents; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Recurrence; Stevens-Johnson Syndrome; Thalidomide; Transplantation, Homologous	2012
Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma. Pharmacotherapy, 2011, Volume: 31, Issue:9 Topics: Aged; Antineoplastic Agents; Female; Humans; Lenalidomide; Multiple Myeloma; Stevens-Johnson Syndrome; Thalidomide	2011
Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Eruptions; Humans; Lenalidomide; Leukemia, Plasma Cell; Male; Middle Aged; Stevens-Johnson Syndrome; Thalidomide	2012
Long-term complete remission in a multiple myeloma patient after Stevens-Johnson syndrome due to lenalidomide therapy. Acta oncologica (Stockholm, Sweden), 2013, Volume: 52, Issue:5 Topics: Aged; Female; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Stevens-Johnson Syndrome; Thalidomide	2013